Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 30 recruiting now early-phase tilt

Hearing Loss: early-phase trial registry

30 of 60 indexed Hearing Loss trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #235 of 28,707 conditions by registered trial count.

60 US clinical trials · 30 currently recruiting · #235 of 28,707 conditions by registered trial count

Hearing Loss: 60 US clinical trials tracked, 30 recruiting.

Hearing Loss is the subject of 60 registered US clinical trials on ClinicalTrials.gov, 30 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is US Department of Veterans Affairs, running 4 of these trials.

Enrollment posture brief

Registry condition hearing-loss

OPEN 30 | RECR 50% | LATE 2 | EARLY 6 | RANK #235 | SPON 4

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Anatomic Stage IV Breast Can70%Physical Inactivity53.3%Prostate Carcinoma51.7%Non-small Cell Lung Cancer50%Hearing Loss (this)50%
Open-enrollment share among volume-matched conditions near Hearing Loss

Hearing Loss lists 30 open slots (50% of 60 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hearing Loss on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hearing Loss is recruiting above its size-band peers.

    30 of 60 indexed trials (50%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Hearing Loss trials is spread across many organizations.

    US Department of Veterans Affairs accounts for 4 of 60 trials (6.7%). 37 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hearing Loss enrolment sits around 100 participants.

    Median target enrolment is 100 among the 59 trials that report a genuine target (sentinel values excluded). 28 of those (47.5%) plan for fewer than 100 participants.

  4. Hearing Loss research is mostly interventional.

    52 interventional and 8 observational studies make up this index (86.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 24Phase 31Phase 41

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 4
Phase 3 1
Phase 4 1

Named interventions

Most-linked intervention names on Hearing Loss records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Automated hearing test/Motivation video Procedure
1 trials
No screening test Procedure
1 trials
Digits-in-noise test Procedure
1 trials
Pure-tone Screener test Procedure
1 trials
Automated hearing test Procedure
1 trials
Lace-DVD Behavioral
1 trials
CONTROL Behavioral
1 trials
PLACEBO-Directed listening Behavioral
1 trials

US sites by state

Facility locations filed on Hearing Loss trials. A trial with sites in several states counts in each.

New York 10 trials
Florida 10 trials
California 10 trials
Texas 9 trials
North Carolina 9 trials
Minnesota 8 trials
Maryland 7 trials
Colorado 7 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hearing Loss page

60 registered trials, 30 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hearing Loss condition card totals 60 registered trials; most-linked intervention Automated hearing test/Motivation video; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.